Robert J. Heine

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Diabetes Management, Cardiovascular Disease, Health Policy +10

Translating the A1C Assay Into Estimated Average Glucose Values

David M. Nathan, J.C. Kuenen, Rikke Borg et al. · Diabetes Care · 2008 · 1.8K citations · Full text

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

K. Borch‐Johnsen, Andrew Neil, Beverley Balkau et al. · The Lancet · 1999 · 1.3K citations

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +9

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

David M. Nathan, John B. Buse, Mayer B. Davidson et al. · Diabetes Care · 2006 · 1.2K citations · Full text

Hypertension, Obesity, Metabolic Syndrome +18

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

Craig J. Currie, John R. Peters, Aodán Tynan et al. · The Lancet · 2010 · 875 citations

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +5